 The consideration of patients ' needs in terms of research outcomes is emphasized in research promotion to eradicate hepatitis<pathogen><disease><symptom> B<pathogen> virus<pathogen> according to the Basic Act on Hepatitis<pathogen><disease><symptom> Measures in Japan. This study analyzed patients ' attitudes toward experienced anti-viral therapies for chronic hepatitis<pathogen><disease><symptom> B<pathogen> and their need for future therapies. A self-administered questionnaire comprising 124 questions was conducted among patients with chronic hepatitis<pathogen><disease><symptom> B<pathogen> from 61 core-center hospitals designated to implement and research policies on hepatitis<pathogen><disease><symptom> in 47 prefectures from August 2013 to January 2014 ( N = 3021 , response rate = 51 %). In decision-tree models with 333 variables generated from the questionnaire data , patients ' satisfaction with therapy and reduction in anxiety<symptom> about therapy were dependent on favorable therapeutic effects , sufficient information provided by the physician , and fewer lifestyle disturbances. Medical expenses were not selected at a superior branch because subsidy for anti-viral therapy started in 2010. In correspondence analysis of free text answers , patients ' need for therapy and support mechanisms differed among their attributes , including a great need for novel therapy in older males , hope for avoidance of lifestyle disturbance in younger males , and alleviation of painful experience with the disease<disease> in females. Continual provision of sufficient information is necessary to improve the utility of anti-viral therapy for chronic hepatitis<pathogen><disease><symptom> B<pathogen> as well as for favorable therapeutic effects. The patients believed that novel drugs and support would reduce the diverse burden of the disease<disease> in their lives.